Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Treatment of chronic myeloid leukemia with autologous transplantation using peripheral blood stem cells or bone marrow cultured in IL-2 followed by IL-2, GM-CSF, and IFN-alpha administration.
Hájek R, Zácková D, Büchler T, Penka M, Krahulcová E, Korístek Z, Vinklárková J, Adler J, Janovská E, Indrák K, Faber E, Doubek M, Klabusay M, Oltová A, Kuglík P, Bourková L, Dusek L, Mareschová I, Mayer J, Vorlícek J. Hájek R, et al. Among authors: vorlicek j. Med Oncol. 2003;20(1):69-76. doi: 10.1385/mo:20:1:69. Med Oncol. 2003. PMID: 12665687 Clinical Trial.
Interleukin-2 activation of haematopoietic stem cells.
Hájek R, Korístek Z, Vinklárková J, Janovská E, Klabusay M, Doubek M, Dvoráková D, Bourková L, Dusek L, Büchler T, Adler J, Adam Z, Penka M, Mayer J, Vorlícek J. Hájek R, et al. Among authors: vorlicek j. Acta Med Austriaca. 2002;29(2):61-7. doi: 10.1046/j.1563-2571.2002.02005.x. Acta Med Austriaca. 2002. PMID: 12050948
Long-term outcomes of autologous transplantation in multiple myeloma: significant survival benefit of novel drugs in post-transplantation relapse.
Krejci M, Scudla V, Tothova E, Schutzova M, Koza V, Adam Z, Krivanova A, Pour L, Buchler T, Sandecka V, Kralova D, Zahradova L, Vorlicek J, Mayer J, Hajek R. Krejci M, et al. Among authors: vorlicek j. Clin Lymphoma Myeloma. 2009 Dec;9(6):436-42. doi: 10.3816/CLM.2009.n.086. Clin Lymphoma Myeloma. 2009. PMID: 19951883
Current role of immunotherapy in multiple myeloma.
Hájek R, Adam Z, Krivanová A, Doubek M, Korístek Z, Vorlícek J. Hájek R, et al. Among authors: vorlicek j. Acta Med Austriaca. 1998;25(3):79-85. Acta Med Austriaca. 1998. PMID: 9816399 Review.
188 results